Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
This review provides an introduction into the fascinating area of organometallic anticancer compounds. Although the subject dates back many years, it has witnessed considerable growth only in the past decade. A brief overview of the subject together with recent pertinent examples is provided. The properties of organometallic compounds that lend themselves to medical applications, the main current approaches used, and possible avenues for future research are identified.
Cite this item
Hartinger, C. G., Metzler-Nolte, N., & Dyson, P. J. (2012). [Review of Challenges and Opportunities in the Development of Organometallic Anticancer Drugs]. Organometallics, 31(16), 5677–5685. https://doi.org/10.1021/om300373t
Click Copy to copy the citation, or select the text manually.
WOS:000308263500003
2012
31
16
5677
5685
REVIEWED
EPFL